Quality improvements in clinical therapeutics

被引:0
|
作者
Dewan, NA [1 ]
机构
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
[2] VAMC, MHCL Cincinnati, Cincinnati, OH USA
关键词
quality of care; technology; medical communication;
D O I
10.1097/00001504-200311000-00021
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review Quality improvement efforts in psychiatry seek to optimize patient centered outcomes in usual care settings. The quality improvement mandate is now part of contractual agreements, performance bonuses for clinical managers, and significant regulatory oversight. The entity seeking to improve quality of care can be a professional organization, a delivery system, a clinical program, or an individual clinician. A whole new era of 'translational research' is underway dedicated to improving quality of care by bringing research knowledge into practice settings. Being current about developments in the field is the first step in improving quality of care. This review summarizes an eclectic mix of information. The articles are included due to the fact they address critical aspects of the structure, process, or outcome of care in usual care settings. Recent findings Quality improvement efforts by their very nature need to borrow information from a variety of disciplines. Hence, this review incorporates recent organizational, neuroscientific, psychological, technological, pharmacological, and clinical findings that can support quality improvements in clinical therapeutics in a variety of settings and scenarios. Summary Research on quality improvement strategies designed to accelerate change and improve clinical communication behaviors should be the next step in improving psychiatric care.
引用
收藏
页码:725 / 729
页数:5
相关论文
共 50 条
  • [21] Platform and Cannula Design Improvements for Spinal Cord Therapeutics Delivery
    Riley, Jonathan P.
    Raore, Bethwel
    Taub, Jason S.
    Federici, Thais
    Boulis, Nicholas M.
    NEUROSURGERY, 2011, 69 : 147 - 154
  • [22] Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures
    Hesse, F
    Wagner, R
    TRENDS IN BIOTECHNOLOGY, 2000, 18 (04) : 173 - 180
  • [23] Placebos and Clinical Therapeutics
    Shader, Richard I.
    CLINICAL THERAPEUTICS, 2017, 39 (07) : 1274 - 1274
  • [24] Clinical therapeutics for phenylketonuria
    Kochhar, Jaspreet Singh
    Chan, Sui Yung
    Ong, Pei Shi
    Kang, Lifeng
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (04) : 223 - 237
  • [25] Clinical Therapeutics in Pregnancy
    Feghali, Maisa N.
    Mattison, Donald R.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [26] Suggested improvements in practice guidelines: Market research to support clinical quality improvement
    Harris, JS
    Mueller, K
    Low, P
    Peplowski, B
    Koziol-McLain, J
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 42 (04) : 377 - 384
  • [27] Equipping clinical leaders for system and service improvements in quality and safety: an Australian experience
    Leggat, Sandra G.
    Smyth, Anne
    Balding, Cathy
    McAlpine, Iain
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2016, 40 (02) : 138 - 143
  • [28] CLINICAL THERAPEUTICS - INTRODUCTION
    FARRAR, GE
    CLINICAL THERAPEUTICS, 1978, 1 : R3 - R3
  • [29] Access to Clinical Therapeutics
    Shader, Richard I.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1601 - 1603
  • [30] Clinical therapeutics for phenylketonuria
    Jaspreet Singh Kochhar
    Sui Yung Chan
    Pei Shi Ong
    Lifeng Kang
    Drug Delivery and Translational Research, 2012, 2 : 223 - 237